Abiopharma

🔍 Strickland Scott R. (Executive)

Company: WYNDHAM HOTELS & RESORTS, INC. (WH)

Report Date: 2026-04-26

Detailed Transactions and Holdings:

• Acquired 1,694 shares of Common Stock (Direct)
  Date: 2026-04-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 46,550.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 867 shares of Common Stock at $85.88 per share (Direct)
  Date: 2026-04-26 | Code: F | equity_swap_involved: 0 | shares_owned_after: 45,683.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-26 | Code: H | shares_owned_after: 44,301.00 | Footnotes: F4

Footnotes:

• F1: Common stock acquired under the Issuer's 2018 Amended and Restated Equity and Incentive Plan on vesting of previously-granted restricted stock units which vested on April 26, 2026.
• F2: Represents shares of common stock.
• F3: Common stock withheld as payment of tax liability incident to the vesting of restricted stock units granted in accordance with Rule 16b-3.
• F4: Represents restricted stock units.